Clinical trials
Diabetes Mellitus trials in China with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
116 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 8 |
| 2011 | 6 |
| 2012 | 11 |
| 2013 | 6 |
| 2014 | 4 |
| 2015 | 9 |
| 2016 | 8 |
| 2017 | 5 |
| 2018 | 6 |
| 2019 | 8 |
| 2020 | 3 |
| 2021 | 7 |
| 2022 | 10 |
| 2023 | 14 |
| 2024 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 116 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking Union Medical College Hospital | 4 |
| Ruijin Hospital | 4 |
| Shanghai 10th People's Hospital | 4 |
| Sun Yat-sen University | 4 |
| Xijing Hospital | 4 |
| First Affiliated Hospital Xi'an Jiaotong University | 3 |
| Guangdong Provincial People's Hospital | 3 |
| Huashan Hospital | 3 |
| Nanjing First Hospital, Nanjing Medical University | 3 |
| Peking University Third Hospital | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus | 116 |
| Diabetes Mellitus, Type 2 | 21 |
| Hypertension | 9 |
| Coronary Artery Disease | 6 |
| Diabetes Mellitus, Type 1 | 6 |
| Metabolic Diseases | 6 |
| Obesity | 6 |
| Cardiovascular Diseases | 5 |
| Insulin Resistance | 5 |
| Diabetic Retinopathy | 4 |
Trials
Showing 1 to 25 of 116. Each trial links to its page on Pharma Observatory.
16 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.